INTERNATIONAL PATENT: THE CHINESE UNIVERSITY OF HONG KONG FILES APPLICATION FOR "LEVERAGING TYPE 2 CYTOKINES TO ENHANCE CELL-BASED THERAPY FOR PERIPHERAL ARTERIAL DISEASES"

GENEVA, Dec. 29 -- THE CHINESE UNIVERSITY OF HONG KONG (Shatin, New TerritoriesHong Kong) filed a patent application (PCT/CN2025/102031) for "LEVERAGING TYPE 2 CYTOKINES TO ENHANCE CELL-BASED THERAPY FOR PERIPHERAL ARTERIAL DISEASES" on Jun 19, 2025. With publication no. WO/2025/261433, the details related to the patent application was published on Dec 26, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): WONG, Wing Tak, Jack (c/o The Chinese University of Hong Kong, Shatin, New TerritoriesHong Kong), LI, Huixian (c/o The Chinese University of Hong Kong, Shatin, New TerritoriesHong Kong), HE, ...